What advancements have we witnessed in the field of immunotherapy for lung cancer and what does the future of this field look like? Find out in this article from Lung Cancer Management.
Discover cases studies of rare recurrences after adjuvant chemotherapy in this Editorial from Future Oncology.
Discover a comprehensive view of the molecular mechanisms involved in colorectal cancer pathogenesis.
Discover details of the KEYNOTE-045, which recently resulted in the recommendation for the use of pembrolizumab within the cancer drugs fund as an option for the treatment of locally advanced or metastatic urothelial carcinoma in adults who have had platinum-containing chemotherapy.
The objective of this study is to identify the effect of diabetes mellitus on survival of patients with pancreatic cancer and to determine whether pancreatic cancer and its treatment affect glycemic control.
Discover an effective biomarker for improving the management of colorectal cancer patients by enhancing the efficiency of detection and efficacy of targeting treatment.
Discover some of the most imporant aspects of colorectal cancer surgery in this review article from Colorectal Cancer Management.
Discover details of the first randomized, multicenter Phase III study to compare the safety and efficacy of mirvetuximab soravtansine vs investigator’s choice of chemotherapy in women with folate receptor-α-positive, platinum-resistant epithelial ovarian, primary peritoneal or fallopian tube cancer.
This retrospective analysis evaluates chemotherapy-induced nausea and vomiting (CINV)-related hydration needs with palonosetron or granisetron extended-release subcutaneous (GERSC), approved in 2016 for CINV prevention.
This review summarizes the past decade of immunotherapy for non-small-cell lung cancer, gives an updated overview of trials in this field, and the context of future development in this exciting field.